Data as of Aug 29
| +0.34 / +3.76%|
The 9 analysts offering 12-month price forecasts for Solazyme Inc have a median target of 14.00, with a high estimate of 18.00 and a low estimate of 4.00. The median estimate represents a +49.25% increase from the last price of 9.38.
The current consensus among 9 polled investment analysts is to Buy stock in Solazyme Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.